Chronic pain after cesarean delivery: what do we know today? A narrative review

被引:0
|
作者
Langenaeken, A. L. [1 ]
Lavand'homme, P. [1 ]
机构
[1] Univ Catholic Louvain, Dept Anesthesiol, Clin Univ St Luc, Brussels, Belgium
关键词
Cesarean delivery; Chronic pain; Chronic postpartum pain; Chronic postsurgical pain; CHRONIC POSTSURGICAL PAIN; PERSISTENT PAIN; POSTOPERATIVE PAIN; REGIONAL ANESTHESIA; RISK-FACTORS; PELVIC PAIN; POSTPARTUM; SECTION; CHILDBIRTH; SURGERY;
D O I
10.1016/j.ijoa.2025.104331
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Childbirth is a major event in life, associated with both physical and psychological changes which may affect women's quality of life. Cesarean delivery (CD) is among the most frequent surgical procedures performed worldwide. Because of the high CD volume and patients' vulnerability (young age and female sex), for chronic postsurgical pain (CPSP), the societal impact of chronic pain after CD requires attention. According to the literature, the incidence of CPSP after CD is highly variable but reasonable evidence suggests a low incidence at six months (3-4%) and later (0.6-0.8%). The recent definition of CPSP in the ICD-11 coding system may not necessarily apply to the specific context of childbirth and CPSP after CD, suggesting that some modifications could be implemented. Interestingly, the incidence of chronic pain after CD is lower than that observed after gynecologic procedures performed in the similar body area. Consequently, since the risk factors do not really differ from those reported for other procedures, the existence of protective factors related to hormonal modulations secondary to pregnancy and lactation have been suggested. Such observations, in preclinical models, also question the pathophysiology of chronic pain after childbirth. Because severe acute postpartum pain is a striking risk factor of CPSP after CD, the preventive effect of different analgesic treatments, mainly regional analgesia techniques, has been evaluated but the results remain disappointing. In conclusion, many questions remain regarding the incidence, pathophysiology and potential prevention of CPSP after CD, and these questions warrant further research.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Caspase-2: What do we know today?
    V. I. Aksenova
    O. V. Bylino
    B. D. Zhivotovsky
    I. N. Lavrik
    Molecular Biology, 2013, 47 : 165 - 180
  • [32] Caspase-2: What do we know today?
    Aksenova, V. I.
    Bylino, O. V.
    Zhivotovsky, B. D.
    Lavrik, I. N.
    MOLECULAR BIOLOGY, 2013, 47 (02) : 165 - 180
  • [33] The mechanism of food allergy: what do we know today?
    Beyer, Kirsten
    Teuber, Suzanne
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 4 (03) : 197 - 199
  • [34] What do we know about French liaison today?
    Durand, Jacques
    Laks, Bernard
    Calderone, Basilio
    Tchobanov, Atanas
    LANGUE FRANCAISE, 2011, (169): : 103 - +
  • [35] Nutrition and Cancer Prevention: What do we know today?
    Giessen, Hannelore
    Kerschbaum, Eva
    Hauner, Dagmar
    Hauner, Hans
    ERNAHRUNGS UMSCHAU, 2021, 68 (03): : M150 - M157
  • [36] Advancements in the management of urologic chronic pelvic pain: What is new and what do we know?
    Parker J.
    Buga S.
    Sarria J.E.
    Spiess P.E.
    Current Urology Reports, 2010, 11 (4) : 286 - 291
  • [37] Political Science in Mexico today: What do we know?
    Gutierrez Escobedo, Angel
    REVISTA MEXICANA DE ANALISIS POLITICO Y ADMINISTRACION PUBLICA, 2014, 3 (02): : 337 - 342
  • [38] Predictors of poor outcomes in juvenile dermatomyositis: what do we know? A narrative review
    Martins, Ana
    Ganhao, Sara
    Aguiar, Francisca
    Rodrigues, Mariana
    Brito, Iva
    REUMATISMO, 2025, 77 (01)
  • [39] Exercise during pregnancy. A narrative review asking: what do we know?
    Barakat, Ruben
    Perales, Maria
    Garatachea, Nuria
    Ruiz, Jonatan R.
    Lucia, Alejandro
    BRITISH JOURNAL OF SPORTS MEDICINE, 2015, 49 (21) : 1377 - 1381
  • [40] What Do We Know About Bacterial Infections in Hidradenitis Suppurativa?-A Narrative Review
    Swierczewska, Zuzanna
    Baranska-Rybak, Wioletta
    ANTIBIOTICS-BASEL, 2025, 14 (02):